Nakanishi
7716.TPrecision Instruments
Financials · Consolidated
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥81.2bn | ¥77.0bn | ¥59.7bn | ¥48.7bn | ¥44.9bn | ¥33.1bn |
| Operating income | ¥14.1bn | ¥14.6bn | ¥14.3bnr | ¥15.4bn | ¥13.8bn | — |
| Ordinary income | ¥16.9bn | ¥17.3bn | ¥17.2bnr | ¥17.6bn | ¥14.0bn | ¥8.6bn |
| Net income (owners) | −¥2.4bn | ¥8.6bn | ¥22.8bnr | ¥12.5bn | ¥10.1bn | ¥6.5bn |
| Total assets | ¥160.2bn | ¥158.3bn | ¥140.8bnr | ¥102.6bnr | ¥94.5bn | ¥82.5bn |
| Net assets / equity | ¥114.1bn | ¥121.2bn | ¥113.2bnr | ¥91.0bn | ¥82.9bn | ¥76.3bn |
| Operating cash flow | ¥16.6bn | ¥15.3bn | ¥8.6bnr | ¥7.8bn | ¥12.0bn | ¥9.2bn |
| EPS (basic) | ¥-28.7 | ¥101.37 | ¥267.62r | ¥145.48 | ¥116.73 | ¥74.49 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 6
| Period | Form | Figures |
|---|---|---|
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 50 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 52 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 76 figures · EDINET |
| 2023-01-01 → 2023-03-31 | Quarterly Q1 | 50 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 52 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 76 figures · EDINET |
22 more reports are still being processed.
Segments · FY ended 2025-12
| Segment | External sales | Profit |
|---|---|---|
| DCI Products | ¥20.5bn | −¥490m |
| Dental Products | ¥48.2bn | ¥16.9bn |
| Industrial Products | ¥6.9bn | ¥817m |
| Surgical Products | ¥5.5bn | ¥2.7bn |
| Adjustments & eliminations | — | −¥5.8bn |
| Total | ¥81.2bn | ¥19.8bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.